In previous researches, we had focused on the effect of LRRC4 on the ERK/MAPK and PI-3K/AKT signaling pathways in gliomas[4], [7], and transcriptional regulation of BRD7 expression in NPCs [18]. This evidence concerns the gene LRRC4 and central nervous system cancer.